EMA launches advisory group on vaccine confidence
The European Medicines Agency (EMA) has established a new advisory group focused on vaccine confidence. This group will provide expert advice to the Agency on issues related to vaccine hesitancy, a critical public health challenge. The EMA aims to guide its actions to increase public trust and understanding of vaccines based on scientific evidence. This initiative underscores the importance of transparent communication and addressing public concerns to maintain high vaccination rates and protect collective health.
EMA tackles vaccine hesitancy with new advisory group, aiming to boost public trust in vaccines.